A detailed history of Isthmus Partners, LLC transactions in Mimedx Group, Inc. stock. As of the latest transaction made, Isthmus Partners, LLC holds 301,500 shares of MDXG stock, worth $2.05 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares
301,500
Previous 216,211 39.45%
Holding current value
$2.05 Million
Previous $1.9 Million 22.42%
% of portfolio
0.27%
Previous 0.25%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

BUY
$7.61 - $8.63 $649,049 - $736,044
85,289 Added 39.45%
301,500 $2.32 Million
Q4 2023

Feb 12, 2024

SELL
$5.7 - $9.14 $912,057 - $1.46 Million
-160,010 Reduced 42.53%
216,211 $1.9 Million
Q3 2023

Nov 14, 2023

SELL
$6.35 - $8.16 $219,221 - $281,707
-34,523 Reduced 8.4%
376,221 $2.74 Million
Q2 2023

Aug 03, 2023

SELL
$3.14 - $6.61 $30,269 - $63,720
-9,640 Reduced 2.29%
410,744 $2.72 Million
Q1 2023

May 10, 2023

BUY
$2.97 - $4.81 $104,579 - $169,369
35,212 Added 9.14%
420,384 $1.43 Million
Q4 2022

Feb 10, 2023

BUY
$2.63 - $3.45 $68,548 - $89,920
26,064 Added 7.26%
385,172 $1.07 Million
Q3 2022

Nov 14, 2022

BUY
$2.71 - $4.22 $111,836 - $174,150
41,268 Added 12.98%
359,108 $1.03 Million
Q2 2022

Aug 08, 2022

BUY
$3.17 - $5.0 $196,438 - $309,840
61,968 Added 24.22%
317,840 $1.1 Million
Q1 2022

May 04, 2022

BUY
$4.27 - $6.27 $173,707 - $255,069
40,681 Added 18.9%
255,872 $1.21 Million
Q4 2021

Jan 25, 2022

BUY
$5.7 - $8.48 $29,925 - $44,520
5,250 Added 2.5%
215,191 $1.3 Million
Q3 2021

Nov 10, 2021

BUY
$5.52 - $15.83 $66,179 - $189,785
11,989 Added 6.06%
209,941 $1.27 Million
Q2 2021

Aug 10, 2021

BUY
$9.02 - $12.72 $7,955 - $11,219
882 Added 0.45%
197,952 $2.48 Million
Q1 2021

May 17, 2021

BUY
$8.48 - $11.28 $1.67 Million - $2.22 Million
197,070 New
197,070 $2.03 Million

Others Institutions Holding MDXG

About MIMEDX GROUP, INC.


  • Ticker MDXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 113,609,000
  • Market Cap $771M
  • Description
  • MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...
More about MDXG
Track This Portfolio

Track Isthmus Partners, LLC Portfolio

Follow Isthmus Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Isthmus Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Isthmus Partners, LLC with notifications on news.